Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

QUANTERIX CORPORATION

(QTRX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
47.71(c) 50.27(c) 47.49(c) 47.56(c) 48.57 Last
142 321 432 871 126 115 103 809 65 234 Volume
+0.42% +5.37% -5.53% +0.15% +2.12% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 101 M - -
Net income 2021 -48,0 M - -
Net cash position 2021 381 M - -
P/E ratio 2021 -32,7x
Yield 2021 -
Sales 2022 123 M - -
Net income 2022 -48,8 M - -
Net cash position 2022 393 M - -
P/E ratio 2022 -32,1x
Yield 2022 -
Capitalization 1 737 M 1 737 M -
EV / Sales 2021 13,4x
EV / Sales 2022 10,9x
Nbr of Employees 314
Free-Float 93,2%
More Financials
Company
Quanterix Corporation develops ultra-sensitive digital immunoassay platform and tools for life science research and diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers. The Company is also focusing to enable and develop novel therapies and diagnostics to facilitate in healthcare for earlier detection, monitoring, prognosis and,... 
More about the company
Ratings of Quanterix Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about QUANTERIX CORPORATION
09/20QUANTERIX : Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
BU
09/13QUANTERIX : Gets FDA Nod for Label Expansion of COVID-19 Antigen Test
MT
09/13QUANTERIX : Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
BU
09/13Quanterix Corporation Receives Label Expansion on Emergency Use Authorization for Covid..
CI
09/10QUANTERIX TO HOST WEBINAR WITH LEADI : “COVID-19 Testing in a Residential University..
BU
09/10QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
09/10Quanterix Corporation Receives Notice from Marijn Dekkers That He Was Resigning as Memb..
CI
08/30CASSAVA SCIENCES : Releases Statement Regarding Plasma p-tau Analysis from a Previously Di..
AQ
08/27SECTOR UPDATE : Health Care Stock Fading Near Friday Close
MT
08/27CASSAVA SCIENCES : Shares Keep Sliding After Company Clarifies Claims on Quanterix Role
MT
08/27SECTOR UPDATE : Health Care Stocks Rising Friday But Lagging Broader Markets
MT
08/27QUANTERIX : Refutes Claim It Prepared Disputed Data Charts Presented by Cassava Sciences t..
MT
08/27QUANTERIX : Releases Statement
BU
08/18INSIDER TRENDS : Insider Disposition Slows 90-Day Buy Trend at Quanterix
MT
08/09QUANTERIX : to Participate in the Canaccord Genuity 41st Annual Growth Conference
BU
More news
News in other languages on QUANTERIX CORPORATION
2020MÄRKTE USA/Nach neuen Rekorden läuft Rally aus
2020MÄRKTE USA/Nach neuen Rekorden schmelzen Gewinne ab
2020MÄRKTE USA/Börsen mit neuen Rekordhochs zu Handelsbeginn
2020MÄRKTE USA/Börsen mit weiteren Gewinnen erwartet
2019QUANTERIX : annonce un accord pour acquérir UmanDiagnostics, premier fournisseur mondial d..
More news
Analyst Recommendations on QUANTERIX CORPORATION
More recommendations
Chart QUANTERIX CORPORATION
Duration : Period :
Quanterix Corporation Technical Analysis Chart | QTRX | US74766Q1013 | MarketScreener
Technical analysis trends QUANTERIX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 47,56 $
Average target price 76,00 $
Spread / Average Target 59,8%
EPS Revisions
Managers and Directors
E. Kevin Hrusovsky Chairman, President & Chief Executive Officer
Michael A. Doyle Chief Financial Officer & Treasurer
David C. Duffy Chief Technology Officer & Vice President-Research
William Geist Chief Operating Officer
Keith L. Crandell Independent Director
Sector and Competitors
1st jan.Capi. (M$)
QUANTERIX CORPORATION2.28%1 737
THERMO FISHER SCIENTIFIC26.71%234 887
DANAHER CORPORATION45.90%231 803
INTUITIVE SURGICAL, INC.23.95%120 661
SIEMENS HEALTHINEERS AG43.02%78 963
EDWARDS LIFESCIENCES CORPORATION29.33%73 864